Anebulo Pharmaceuticals, Inc. Competitors
Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|---|
ACRV
|
Acrivon Therapeutics, Inc. Common Stock | $6.45 | $223.86 M | -2.51 | 58 | $0 |
ADAG
|
Adagene Inc. | $2.31 | $131.46 M | -6.77 | 174 | $18.11 M |
ANAB
|
AnaptysBio, Inc. | $21.14 | $640.07 M | -3.82 | 117 | $17.16 M |
ANTX
|
AN2 Therapeutics, Inc. | $1.40 | $60.55 M | -0.81 | 41 | $0 |
AVTE
|
Aerovate Therapeutics, Inc. | $2.65 | $597.48 M | -6.84 | 51 | $0 |
MLYS
|
Mineralys Therapeutics, Inc. | $12.15 | $652.38 M | -6.03 | 28 | $0 |
MOLN
|
Molecular Partners AG | $5.34 | $135.05 M | -2.03 | 167 | $7.04 M |
OPT
|
Opthea Limited | $3.17 | $214.34 M | -1.04 | 33 | $261,859 |
PMVP
|
PMV Pharmaceuticals, Inc. | $1.60 | $85.40 M | -1.26 | 63 | $0 |